Evidence map›Paper›PMID 32198492›Full record

ArticleNature chemical biology2020

Crystal structure of human PLD1 provides insight into activation by PI(4,5)P

Forrest Z Bowling, Christian M Salazar, Justin A Bell, Tahrima S Huq, Michael A Frohman, Michael V Airola

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Forrest Z BowlingDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY, USA.
Christian M SalazarDepartment of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, USA.
Justin A BellDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY, USA.
Tahrima S HuqDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY, USA.
Michael A FrohmanDepartment of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, USA.
Michael V AirolaDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY, USA. michael.airola@stonybrook.edu.ORCID http://orcid.org/0000-0003-4981-1253
Stony Brook University · US

Funding

X-ray Scattering Technology CoreP30GM133893 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI Sean McSweeney · 2019 to 2026
$38.6M
Life Science and Biomedical technology Research center at NSLS-II LSBRP41GM111244 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MCSWEENEY, SEAN · 2014 to 2018
$16.4M
Training Program in Pharmacological SciencesT32GM007518 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI GARCIA-DIAZ, MIGUEL · 1985 to 2021
$5.4M
Structure and regulation of lipid metabolism and transportR35GM128666 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI Michael Virgil Airola · 2018 to 2026
$4.0M
Lipid-signaling pathways regulating mitochondrial morphology, energetics, and movR01GM084251 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI FROHMAN, MICHAEL A. · 2009 to 2017
$2.6M
High-Speed High-Sensitivity Detector for X-ray Micro-Crystallography at GM/CA@APSS10OD012289 · OD · UNIVERSITY OF CHICAGO · PI FISCHETTI, ROBERT F. · 2014 to 2014
$2.0M
SBU Chemistry-Biology Interface Training ProgramT32GM092714 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI SAMPSON, NICOLE S, TONGE, PETER J · 2010 to 2019
$1.7M
NIGMS NIH HHS P30 GM133893NIGMS NIH HHS P41 GM111244NIGMS NIH HHS R01 GM084251NIGMS NIH HHS R35 GM128666NIGMS NIH HHS T32 GM007518NIGMS NIH HHS T32 GM092714NIH HHS S10 OD012289U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM084251U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) T32GM092714
6 · The paper itself

Abstract

The signal transduction enzyme phospholipase D1 (PLD1) hydrolyzes phosphatidylcholine to generate the lipid second-messenger phosphatidic acid, which plays roles in disease processes such as thrombosis and cancer. PLD1 is directly and synergistically regulated by protein kinase C, Arf and Rho GTPases, and the membrane lipid phosphatidylinositol-4,5-bisphosphate (PIP

Indexed as

AnimalsCatalysisCatalytic DomainChlorocebus aethiopsCOS CellsHumansMembrane LipidsPhosphatidylcholinesPhosphatidylinositol 4,5-DiphosphatePhospholipase DProtein BindingProtein Kinase CrhoA GTP-Binding ProteinSecond Messenger SystemsSignal TransductionMembrane LipidsPhosphatidylcholinesPhosphatidylinositol 4,5-DiphosphatePhospholipase Dphospholipase D1Protein Kinase CrhoA GTP-Binding ProteinRHOA protein, human

Identifiers

PMID32198492
PMCPMC7117805
OpenAlexW3012366502

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.